What is Remdesivir?
Remdesivir (GS-5734) is an investigational antiviral drug developed by Gilead Sciences. It is a novel, oral, single-agent therapy that is being developed for the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) infections.
How does Remdesivir work?
Remdesivir is a nucleoside analogue that inhibits the replication of SARS-CoV and MERS-CoV by blocking the viral RNA-dependent RNA polymerase.
What is the Remdesivir cocktail?
The Remdesivir cocktail is a combination of Remdesivir, …
0